Stem cell bone graft shows promise for back pain relief

NCT ID NCT00941980

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested Osteocel Plus, a bone graft material that contains stem cells, in 28 adults with degenerative disc disease who needed spinal fusion surgery. The goal was to see if it helps the spine bones fuse together as well as standard bone grafts. Researchers measured fusion rates and complications over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Osteocel Plus (a stem cell bone graft)

What this could lead to

If successful, this could offer a safer alternative to traditional bone grafts for spinal fusion, reducing the need for a second surgical site.

What could go wrong

This is a small, early study with only 28 participants, so results may not apply to everyone. There is also a risk of complications like infection or non-union of the spine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intervertebral disk degenerative disorder lumbar disk degenerative disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Spine, Orthopaedic Rehabilitation Center, Lovelace Medical Center

    Albuquerque, New Mexico, 87102, United States